
Company Info
Year Established2022
Contacts
Michael A. Egan, Ph.D.CEO & CSO
Company Description
CastleVax is a clinical-stage vaccine research and development company devoted to the commercial development of the NDV vaccine platform technology with an initial focus on respiratory viruses.